12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Eperzan albiglutide regulatory update

GlaxoSmithKline said FDA extended the PDUFA date by 3 months for a BLA for albiglutide to treat Type II diabetes. The new date is April 15, 2014;...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >